Showing all 9 results

Show sidebar
Show 9 12 18 24
Compare

Cibinqo (abrocitinib)

£1,571.70 – £1,958.53
Cibinqo (abrocitinib) is a prescription medicine used to treat adults and adolescents 12 years of age and older with moderate-to-severe atopic dermatitis, also known as atopic eczema.
Add to wishlist
Select options
Quick view
Compare

Ilumya (tildrakizumab)

£679.18
Ilumya (tildrakizumab) is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections, pills (systemic therapy), or phototherapy (treatment using ultraviolet or UV light).
Add to wishlist
Add to cart
Quick view
Compare

Olumiant (baricitinib)

£1,306.70 – £4,455.46
Olumiant (baricitinib) is a medication used for the treatment of rheumatoid arthritis and for the treatment of moderate to severe atopic dermatitis. On November 19, 2020 the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Olumiant (baricitinib), in combination with Veklury (remdesivir), to treat COVID-19 patients.
Add to wishlist
Select options
Quick view
Compare

Opzelura (ruxolitinib)

£1,244.38
Opzelura (ruxolitinib) is a prescription cream used on the skin (topical) for:
  • (short-term) treatment of chronic mild to moderate eczema (atopic dermatitis) in patients 12 years or older who aren’t suitable for or have failed other topical prescription drugs (approved by the FDA on Sept 21, 2021);
  • Treatment of non-segmental vitiligo in adults and children over 12 years of age (approved by the EMA on April, 2023).
Add to wishlist
Select options
Quick view
Compare

Skilarence (dimethyl fumarate)

£216.43 – £384.64
Skilarence (dimethyl fumarate) is a medication used for the treatment of moderate to severe plaque psoriasis.
Add to wishlist
Select options
Quick view
Compare

Stelara (ustekinumab)

£7,079.70
Stelara (ustekinumab) is a medication used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease, or ulcerative colitis.
Add to wishlist
Select options
Quick view
Compare

Takhzyro (lanadelumab)

£17,142.03
Takhzyro (lanadelumab) is a medicine for the prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older. It is available as solution for injection in single-dose, ready-to-use vial.
Add to wishlist
Select options
Quick view
Compare

Taltz (ixekizumab)

£3,185.16
Taltz (ixekizumab) is a medication used for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis.
Add to wishlist
Add to cart
Quick view
Compare

Tremfya (guselkumab)

£3,510.00
Tremfya (guselkumab) is a medication used for the treatment of adult patients with moderate-to-severe plaque psoriasis and active psoriatic arthritis.
Add to wishlist
Select options
Quick view